Korro Bio announces preclinical results for KRRO-111 in alpha-1 antitrypsin deficiency

Korro Bio announced preclinical results showing KRRO-111 has potential to treat both lung and liver manifestations of alpha-1 antitrypsin deficiency.

Detected & updated continuously · Source: Nebula